|4Feb 23, 7:42 PM ET

Barclay Alec 4

4 · T2 Biosystems, Inc. · Filed Feb 23, 2022

Insider Transaction Report

Form 4
Period: 2022-02-20
Barclay Alec
SVP, Operations
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2022-02-2110,0000 total
    Common Stock (10,000 underlying)
  • Exercise/Conversion

    Common Stock

    2021-02-21+10,00084,420 total
  • Tax Payment

    Common Stock

    2021-02-21$0.47/sh5,275$2,45879,145 total
  • Award

    Restricted Stock Units

    2022-02-20+600,000600,000 total
    Common Stock (600,000 underlying)
Footnotes (4)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]5,275 shares of common stock were automatically withheld at vesting to cover required tax withholding.
  • [F3]On February 20, 2022 the reporting person was granted 600,000 RSU's that vest in three equal annual installments commencing on February 20, 2022.
  • [F4]On February 21, 2019 the reporting person was granted 30,000 RSU's that vest in three equal annual installments commencing on February 21, 2020..

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION